Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. A serological test was developed in April 2020 in response to the global COVID-19 pandemic. The MosaiQ COVID-19 Antibody Microarray is CE marked and available for distribution in Europe including Switzerland, and the UK. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania. The Quotient logo, Quotient MosaiQ and MosaiQ are trademarks or registered trademarks of Quotient Limited or its subsidiaries in various jurisdictions.
Location: Switzerland, Vaud, Eysins
Member count: 201-500
Total raised: $16.2M
Founded date: 2007
Investors 2
| Date | Name | Website |
| - | Galen Part... | galen.com |
| - | Sophia Bus... | sophiabusi... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 26.02.2013 | - | $5M | - | finsmes.co... |
| 06.03.2012 | - | $11.2M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 03.02.2023 | Four Sure-Fire Ways To Become A Value Creator In Your Busine... | Manuel O. Méndez, Chief Executive Officer of Quotient Limited. getty Each of us has the power ... | forbes.com... |
| 24.05.2021 | QUOTIENT LIMITED Quotient Limited : Announces New $95 Milli... | Transaction proceeds will be used to fund the further development of the MosaiQ platform beyond the ... | marketscre... |
| 26.02.2013 | Quotient Biodiagnostics Raises Additional $5M | Quotient Biodiagnostics, a global transfusion diagnostics group, Raised an additional $5.0m in equit... | finsmes.co... |
| 06.03.2012 | Quotient Biodiagnostics Closes $11.2M Growth Equity Financin... | Quotient Biodiagnostics Holdings Limited, a global transfusion diagnostics group, has completed an $... | finsmes.co... |
| 19.03.2010 | Haemonetics licenses Alba Bioscience blood typing reagents | Haemonetics Corp. (NYSE:HAE) inked a deal with Quotient Biodiagnostics Group subsidiary Alba Bioscie... | massdevice... |